Jun 20 |
Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation
|
Jun 16 |
Enzo Biochem Third Quarter 2024 Earnings: US$0.042 loss per share (vs US$0.31 loss in 3Q 2023)
|
Jun 14 |
Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up
|
Jun 13 |
Enzo Biochem Non-GAAP EPS of -$0.03, revenue of $8.02M
|
Jun 13 |
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
|
Mar 14 |
Enzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years ago
|
Mar 13 |
Enzo Biochem Non-GAAP EPS of $0.00, revenue of $8.55M
|
Mar 13 |
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
|
Feb 1 |
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
|
Jan 30 |
Here’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)
|